|
A plenary lecture is featured both on Monday and Wednesday mornings during the ACT meeting. The Program Committee is selecting interesting and timely speakers for the ACT Annual Meeting Plenary Lectures.
Monday, November 5, 7:45 AM–8:40 AM
A More Dangerous “Heroin”: Lessons Learned from Street-Based Research in Four US Fentanyl Hotspots
 Daniel Ciccarone, MD, MPH
Professor, Family and Community Medicine, University of California, San Francisco
Dr. Dan H. Ciccarone, MD, MPH, is a professor in the Department of Family and Community Medicine at the University of California, San Francisco. Dr. Ciccarone has been principal or co-investigator on numerous NIH-sponsored public health research projects. Currently, he is leading the “Heroin in Transition” study, which examines utilizing an integrated multidisciplinary approach—ethnographic, economic, and statistical modeling—the recent rise in heroin use and the expanding diversity of heroin source-forms and illicitly made synthetic opioids (e.g., fentanyls) and their relationship to sharp increases in illicit opioid-involved morbidity and mortality. His publications have appeared in JAMA, NEJM, AJPH, IJDP, and PLoS Medicine. Also, he is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the “triple wave crisis” of opioids, heroin, and fentanyl in the United States.
Wednesday, November 7, 8:00 AM–8:55 AM
Studies of Domestic Dogs Facilitates Understanding of Human Health and Biology
Elaine A. Ostrander, PhD
Chief and Distinguished Investigator, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH
Dr. Elaine A. Ostrander is chief of the Cancer Genetics and Comparative Genomics Branch at the National Human Genome Research Institute of NIH, and she is head of the Section on Comparative Genetics. She received her PhD from Oregon Health Sciences University in 1987 and completed postdoctoral training at Harvard and University of California, Berkeley. Dr. Ostrander initiated the canine genome project in 1993, building maps to navigate the dog genome. Her current work focuses on finding genes controlling morphologic variation and disease susceptibility. She was a faculty member at the Fred Hutchinson Cancer Research Center for 12 years, and then she moved to NIH in 2004. Dr. Ostrander has published more than 340 papers, edited multiple books, and has won several awards—including the American Cancer Society Junior Faculty Award, the Burroughs Welcome Award for Functional Genomics, the Asa Mays Award, the International Canine Health Lifetime Achievement Award, and the 2013 Genetics Society of America Medal.
|